Loading...

Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.

BACKGROUND: Several therapies have recently been approved for use in the NHS for pretreated advanced or metastatic renal cell carcinoma (amRCC), but there is a lack of comparative evidence to guide decisions between them. OBJECTIVE: To evaluate the clinical effectiveness and cost-effectiveness of ax...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Health Technol Assess
Main Authors: Edwards, Steve J, Wakefield, Victoria, Cain, Peter, Karner, Charlotta, Kew, Kayleigh, Bacelar, Mariana, Masento, Natalie, Salih, Fatima
Format: Artigo
Sprog:Inglês
Udgivet: NIHR Journals Library 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5817410/
https://ncbi.nlm.nih.gov/pubmed/29393024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta22060
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!